Trial Profile
A Phase 3 trial of Isatuximabin 1st line Multiple Myeloma in SCT eligible patients (GMMG)
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 07 May 2018
Price :
$35
*
At a glance
- Drugs Isatuximab (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 07 May 2018 New trial record
- 27 Apr 2018 According to a Sanofi media release, the trial is planned to start in Q3 2018.